Bumper Offer - Urjas oil Just @ Rs. 1 X
Oleanz RT 2.5 Tablet is a prescription medicine that is available as a Tablet. Schizophrenia are some of its major therapeutic uses. The alternative uses of Oleanz RT 2.5 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Oleanz RT 2.5 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Oleanz RT 2.5 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Oleanz RT 2.5 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Oleanz RT 2.5 Tablet's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Oleanz RT 2.5 Tablet related warnings talks about Oleanz RT 2.5 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Tardive Dyskinesia, Depression must refrain from the use of Oleanz RT 2.5 Tablet since this can cause severe adverse effects. The section on Oleanz RT 2.5 Tablet contraindications lists all such conditions.
Besides this, Oleanz RT 2.5 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Oleanz RT 2.5 Tablet is not safe while driving, and is is not addictive in nature.
Oleanz RT 2.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Oleanz RT 2.5 Tablet is used -
Moderate
Mild
Is the use of Oleanz RT 2.5 Tablet safe for pregnant women?
Oleanz RT can have harmful effects in pregnant women. If you experience any discomfort after using Oleanz RT, then discontinue the use and take your doctor's advice.
Is the use of Oleanz RT 2.5 Tablet safe during breastfeeding?
Oleanz RT may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Oleanz RT 2.5 Tablet on the Kidneys?
There are no side effects of Oleanz RT on the kidneys.
What is the effect of Oleanz RT 2.5 Tablet on the Liver?
Oleanz RT has very mild side effects on the liver.
What is the effect of Oleanz RT 2.5 Tablet on the Heart?
Oleanz RT has very mild side effects on the heart.
Oleanz RT 2.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Oleanz RT 2.5 Tablet unless your doctor advises you to do so -
Is this Oleanz RT 2.5 Tablet habit forming or addictive?
Oleanz RT 2.5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Oleanz RT 2.5 Tablet as you may feel sleepy.
Is it safe?
Yes, but take Oleanz RT 2.5 Tablet only as per medical advice.
Is it able to treat mental disorders?
Oleanz RT 2.5 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Oleanz RT 2.5 Tablet
Oleanz RT 2.5 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Oleanz RT 2.5 Tablet
Taking Oleanz RT 2.5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 932-934
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 442
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Intramuscular (olanzapine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zyprexa Relprevv (olanzapine)